Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crinetics Pharmaceuticals (CRNX) Inventory (2025)

Crinetics Pharmaceuticals has reported Inventory over the past 1 years, most recently at $2.0 million for Q4 2025.

  • Quarterly results put Inventory at $2.0 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $2.0 million (changed N/A YoY), and the annual figure for FY2025 was $2.0 million, changed.
  • Inventory for Q4 2025 was $2.0 million at Crinetics Pharmaceuticals.
  • Over the last five years, Inventory for CRNX hit a ceiling of $2.0 million in Q4 2025 and a floor of $2.0 million in Q4 2025.